Bain Capital Life Sciences IV General Partner, LLC
- SEC CIK
- 0001996931
No open-market purchases or sales filed in the past year.
Current role at each company
- KLRA Kailera Therapeutics, Inc.10% Owneras of Apr 20, 2026
- OLMA Olema Pharmaceuticals, Inc.10% Owneras of Jan 13, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bain Capital Life Sciences IV General Partner, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KLRA Kailera Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing)6:01 PM ET | Apr 20 | Same day | Bain Capital Life Sciences Investors, LLC and 4 others10% Owner | PPurchase | +1.56M | $16.00 | +$25.0M | +7.4%22.6M after | Duplicate filing |
OLMA Olema Pharmaceuticals, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2025 (view filing)4:34 PM ET | Jan 8 | 5 days | Bain Capital Life Sciences Investors, LLC and 4 others10% Owner | PPurchase | +300.0K | $5.76 | +$1.73M | +4.0%7.80M after |